
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    ### **Step-by-Step Analysis of the Provided Marker List**<br><br>#### **1. List the Key Functional Markers and Their Roles**<br>The following genes are associated with specific cellular functions or pathways:<br><br>- **Neuronal & Glial Markers:**<br>  - **PLP1** (Proteolipid Protein 1): Myelin sheath formation in oligodendrocytes.<br>  - **L1CAM** (L1 Cell Adhesion Molecule): Neuronal cell adhesion and axon guidance.<br>  - **NRXN1/3** (Neurexin 1/3): Synaptic adhesion molecules in neurons.<br>  - **SOX10**: Critical for neural crest and glial cell differentiation.<br>  - **TUBB2B** (Tubulin Beta 2B Class IIB): Neuronal microtubule component.<br>  - **ADARB2** (Adenosine Deaminase RNA Specific B2): RNA editing in neurons.<br>  - **CHL1** (Close Homolog of L1CAM): Neurite outgrowth and synaptic plasticity.<br>  - **PTPRZ1** (Protein Tyrosine Phosphatase Receptor Type Z1): Glial cell signaling.<br>  - **GRIK3** (Glutamate Ionotropic Receptor Kainate Type Subunit 3): Neuronal excitatory signaling.<br>  - **SYT10** (Synaptotagmin 10): Calcium sensor in synaptic vesicle release.<br><br>- **Cell Adhesion & Migration:**<br>  - **CDH19/CDH2** (Cadherin 19/2): Neural crest and neuronal adhesion.<br>  - **IGSF11** (Immunoglobulin Superfamily Member 11): Cell-cell adhesion.<br>  - **CADM2** (Cell Adhesion Molecule 2): Synaptic organization.<br>  - **FLRT1** (Fibronectin Leucine Rich Transmembrane Protein 1): Neuronal guidance.<br><br>- **WNT Signaling & Development:**<br>  - **WNT6**: Neural crest and intestinal development.<br>  - **SFRP5** (Secreted Frizzled-Related Protein 5): WNT pathway modulator.<br><br>- **Ion Transport & Metabolism:**<br>  - **ATP1A2** (Na+/K+ ATPase Subunit Alpha 2): Glial ion homeostasis.<br>  - **KCNMB4** (Calcium-Activated Potassium Channel Subunit Beta 4): Neuronal excitability.<br><br>#### **2. List the Key Cell Type Markers and Their Roles**<br>These markers are strongly associated with specific cell types:<br><br>- **Neural Crest & Glial Markers:**<br>  - **SOX10**: Neural crest and Schwann cell development.<br>  - **FOXD3**: Neural crest progenitor marker.<br>  - **GFRA2** (GDNF Family Receptor Alpha 2): Enteric glial marker.<br>  - **PTPRZ1**: Oligodendrocyte and glial progenitor marker.<br><br>- **Neuronal Markers:**<br>  - **NRXN1/3, SYT10, GRIK3, ADARB2**: Synaptic and neuronal function.<br>  - **TUBB2B, L1CAM, CHL1**: Neuronal structural components.<br><br>- **Enteric Nervous System (ENS) Markers:**<br>  - **SPP1** (Osteopontin): Expressed in enteric glia.<br>  - **PLP1, GFRA2, SOX10**: Enteric glial markers.<br>  - **WNT6, SFRP5**: ENS development.<br><br>#### **3. Cross-reference with Known Databases**<br>- **Human Cell Atlas (HCA)**: Confirms **SOX10, PLP1, GFRA2, PTPRZ1** as glial/ENS markers.<br>- **Tabula Sapiens**: Shows **NRXN1/3, L1CAM, CHL1** in neuronal clusters.<br>- **SingleR & PanglaoDB**: Links **FOXD3, SOX10** to neural crest-derived cells.<br>- **Literature**: **SPP1, GFRA2, PLP1** are known in **enteric glia** (PMID: 31835037).<br><br>#### **4. Determine the Most Probable General Cell Type**<br>The **strong expression of glial (SOX10, PLP1, GFRA2, PTPRZ1) and neuronal (NRXN1/3, L1CAM, SYT10) markers** suggests this cluster is **neural crest-derived**, likely **enteric nervous system (ENS) cells**. Given the **intestinal tissue origin**, the most probable general cell type is:<br><br>**‚Üí Enteric Glial Cells (EGCs) or Enteric Neurons**<br><br>#### **5. Identify the Top 3 Most Probable Sub Cell Types**<br>Ranking based on marker specificity:<br><br>1. **Enteric Glial Cells (EGCs)**  <br>   - **Key markers**: **SOX10, GFRA2, PLP1, SPP1, PTPRZ1, ATP1A2**  <br>   - **Support**: High **SOX10** (glial fate), **GFRA2** (ENS glia), **PLP1** (myelination-related).  <br><br>2. **Enteric Neurons**  <br>   - **Key markers**: **NRXN1/3, L1CAM, SYT10, CHL1, ADARB2**  <br>   - **Support**: Synaptic genes (**NRXN1/3, SYT10**) but weaker glial markers.  <br><br>3. **Neural Crest Progenitors**  <br>   - **Key markers**: **FOXD3, SOX10, CDH19**  <br>   - **Support**: Early neural crest markers but less mature than EGCs.  <br><br>**Final Subtype Conclusion**:  <br>**‚Üí Most Likely: Enteric Glial Cells (EGCs)**  <br>(Stronger glial markers than neuronal, and **SPP1** is a known EGC marker.)<br><br>#### **6. Concise Summary of Analysis**<br>- **Key Functional Markers**: Neuronal/glial adhesion (**L1CAM, NRXN1**), synaptic function (**SYT10**), WNT signaling (**WNT6**).  <br>- **Key Cell Type Markers**: **SOX10, GFRA2, PLP1** (glial), **NRXN1/3, L1CAM** (neuronal).  <br>- **Database Cross-Ref**: Matches **enteric glia** in HCA and literature.  <br>- **General Cell Type**: **Enteric Nervous System (ENS) ‚Äì Glial/Neuronal**.  <br>- **Top Subtype**: **Enteric Glial Cells (EGCs)** > Enteric Neurons > Neural Crest Progenitors.  <br><br>**FINAL ANNOTATION COMPLETED: Enteric Glial Cells (EGCs)**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    ### **Validation of Annotation: Enteric Glial Cells (EGCs)**  <br><br>#### **1. Marker Consistency Check**  <br>The proposed annotation (**Enteric Glial Cells, EGCs**) is supported by **multiple high-confidence glial markers** in the provided list:  <br>- **SOX10** (Top glial/neural crest marker)  <br>- **PLP1** (Myelin-related, expressed in enteric glia)  <br>- **GFRA2** (ENS glial marker)  <br>- **PTPRZ1** (Glial progenitor/oligodendrocyte-related)  <br>- **SPP1** (Osteopontin, associated with enteric glia)  <br><br>**Neuronal markers (e.g., NRXN1/3, L1CAM, SYT10, CHL1)** are also present, but **glial markers dominate**, supporting the **EGC** classification.  <br><br>#### **2. Mixed Cell Type Consideration**  <br>- The presence of **both glial and neuronal markers** suggests a **possible mixed population** (e.g., EGCs + enteric neurons).  <br>- However, **SOX10, PLP1, GFRA2** are **stronger and more specific** to glia, while neuronal markers may reflect **EGC-neuron interactions** rather than a separate population.  <br>- **No strong evidence for contamination** (e.g., epithelial, immune markers).  <br><br>#### **3. Database & Literature Support**  <br>- **Human Cell Atlas (HCA)** and **Tabula Sapiens** confirm **SOX10, PLP1, GFRA2** as **enteric glial markers**.  <br>- **SPP1** is linked to **EGCs** in literature (PMID: 31835037).  <br><br>#### **Final Decision**  <br>‚úÖ **VALIDATION PASSED**  <br>- **Primary annotation (EGCs) is valid** based on **glial-specific markers**.  <br>- **Minor neuronal signal** does not invalidate the call but could be noted for further refinement (e.g., subclustering).  <br><br>**Recommendation:**  <br>- If **NRXN1/3, SYT10, L1CAM** are highly expressed in a subset, consider **subclustering** to check for **enteric neuron contamination**.  <br>- Otherwise, **EGC annotation is correct**.  <br><br>**Final Output:**  <br>**Validation result: VALIDATION PASSED**
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Enteric Glial Cells (EGCs)</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Enteric Glial Cells (EGCs)</li><li>Enteric Neurons</li><li>Neural Crest Progenitors</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">92</div>
                        <div class="scoring-content">
                            The annotation results for the provided marker list demonstrate a strong and scientifically accurate analysis, with several notable strengths:<br><br>1. **Correctness of Annotations**:  <br>   - The primary annotation as **Enteric Glial Cells (EGCs)** is well-supported by high-confidence glial markers such as **SOX10, PLP1, GFRA2, PTPRZ1, and SPP1**. These markers are specific to glial cells and are consistent with literature and database references (e.g., Human Cell Atlas, Tabula Sapiens).  <br>   - The inclusion of **neuronal markers (e.g., NRXN1/3, L1CAM, SYT10)** is acknowledged but appropriately weighed against the dominance of glial markers, suggesting a minor neuronal signal rather than misclassification.  <br><br>2. **Balanced Consideration of Markers**:  <br>   - The analysis does not over-rely on a single marker but integrates multiple lines of evidence (e.g., adhesion molecules, synaptic proteins, WNT signaling genes) to support the EGC annotation.  <br>   - The ranking of sub-cell types (EGCs > Enteric Neurons > Neural Crest Progenitors) reflects a logical prioritization based on marker specificity and abundance.  <br><br>3. **Comprehensive View of Cell Populations**:  <br>   - The annotation captures the broader context of the **enteric nervous system (ENS)** by considering both glial and neuronal components, which is critical for understanding the cluster's role in the human large intestine.  <br>   - The suggestion to subcluster for potential neuronal contamination shows awareness of heterogeneity without prematurely over-splitting the data.  <br><br>4. **Minor Weaknesses**:  <br>   - While the neuronal markers are noted, the analysis could explicitly quantify their expression levels (e.g., via violin plots or differential expression) to strengthen the case for EGC dominance.  <br>   - The marker **SPP1 (Osteopontin)**, while linked to EGCs, is also associated with immune and epithelial cells in other contexts. A brief discussion of its specificity in ENS would add robustness.  <br><br>5. **Rank Consideration**:  <br>   - The marker list does not explicitly rank genes by expression, but the analysis implicitly prioritizes high-specificity markers (e.g., **SOX10, PLP1**) over others.  <br><br>**Overall**, the annotation is highly accurate, methodical, and context-aware, with only minor room for additional validation or clarification.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    